Post Profile

A New Strategy to Undermine Big Pharma’s Price Gouging Actually Worked

Last week, the Food and Drug Administration announced its approval of the drug benznidazole, which is used to treat a parasitic disease that afflicts about 300,000 Americans and that, left untreated, can lead to heart failure. It sounds like a routine case of government agencies doing routine work—a relief during the Trump administration. For once, there’s good news.
read more


Related Posts

FDA Approves New Medtronic Left Heart Lead For Cardiac Resynchronization Therapy Devices

Health : Medical News Today

Medtronic, Inc. (NYSE: MDT) announced U.S. Food and Drug Administration (FDA) approval and availability of the Attain Ability® left‐heart lead (Model 4196) for use with cardiac resynchronization therapy (CRT) devices for heart fai...

Drug shortage leaves thousands with Chagas disease untreated

Health : Health

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most countries where Chagas is endemic. The shortage comes at a time when a number of countrie...

The Next Big Drug to Treat Heart Disease

Health : Time: Healthland

The Food and Drug Administration may soon approve blockbuster drugs that can lower cholesterol better than anything on the market today. Here’s what you need to know about the heart disease game changers.

FDA approves Impavido to treat tropical disease leishmaniasis

Health : Medical News Today

The U.S. Food and Drug Administration has approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis.Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted to humans through sand fly b...

Breakthrough Heart Failure Drug Approved

Health : Time: Healthland

The U.S. Food and Drug Administration (FDA) has approved a new drug for heart failure that some say could replace current drugs and procedures used to treat the condition. On Tuesday, the FDA approved drug company Novartis’ Entresto...


Copyright © 2016 Regator, LLC